For its fifth consecutive year, HTID® has the distinguished honor of being placed under the High Patronage of Mr. Emmanuel MACRON, President of the French Republic. The event is enhanced by the involvement of eminent personalities from different European institutions:

• European Commission, DG Santé: Ms. Olga Solomon, Head of unit for medicines: policy, authorization, and monitoring
• European Commission, HERA (Health European Preparedness and Response Authority): M. Pierre Delsaux, General Director
• European Investment Fund - Mr. Alain Godard, CEO of the European Fund for Digital Sovereignty
• European Investment Bank: Ms. Dana Burduja, Head of the Life Sciences and Health Division,
• European Innovation Council (EIC): Mr. Iordanis Arzimanoglou, Head of the Health and Biotechnology Program - Mr. Enric Claverol Tinture, Head of the Medical Technologies Program
• Israel Innovation Authority: Mr. Shlomi Kofman, Vice President of the International Division,

This year, discussions will be focused on the challenges related to the competitiveness of the European healthcare industry, equal access to innovation for all, and the impact of legislative developments in Europe and the United States.

"Europe has the potential to excel across the entire life sciences value chain. This potential spans from academic research to the support and financing of startups. Although the European ecosystem is relatively young, unmistakable signs point to Europe's imminent emergence as a global healthcare power for the benefit of patient wellness.” Maryvonne Hiance, President of the HealthTech For Care endowment fund.

Find the full program and speakers here.

Since its inception, HealthTech For Care has the support of life sciences sector’ sponsors including: Alira Health, Amgen France, BNP Paribas, bpifrance, Bristol Myers Squibb, Cepton Strategies - Vintura, Euronext, Icosa, Invest Securities, Ipsen, Life Sciences Acceleration Alliance, Mapi Research Trust, McDermott Will & Emery, Peak Lifecycles, Rothschild & Co, Sanofi, Servier, Sofinnova Partners

The program of roundtable discussions for this 5th edition is structured around four major themes:

1. Towards a Dynamic and Stable European Health

European nations share common goals in terms of improving the quality of life and increasing life expectancy. This convergence must lead the European Union to develop a strategy to advance the "right to access healthcare for all" and address the challenges of financing and innovation, to build a healthcare Europe that serves all EU citizens and patients, including legislation adapted to European issues. Two round tables and two keynotes will address these issues:

• Making the EU a more attractive playing field today and for the future,
• Macroeconomic environment of healthcare innovation for European citizens,
• HERA Keynote with the participation of Pierre Delsaux, General Director, European Commission, HERA (Health European Preparedness and Response Authority)
• European Fund for Digital Sovereignty Keynote with the participation of Alain Godard, Chairman & Managing Director of the European Fund for Digital Sovereignty.

2. The New Frontiers of Healthcare

Innovations in oncology and in the digital realm: the metaverse is accelerating progress in all scientific areas. Four roundtables will provide an overview of the new frontiers of innovation:

• Oncology: new tools to optimize the development of therapeutic solutions, from discovery to lifecycle management,
• The virtual world in healthcare technologies, what does it bring to patients?
• Metabolic diseases: trends and financing & innovation questions,
• Non-invasive therapies: toposteric effect.

3. The Challenge of Healthcare Innovation Financing

HealthTech companies need strong financial support at every stage of their development. They rely on public funding mechanisms and a network of specialized life sciences investors that must constantly adapt to an unstable environment. Six roundtables will address financing challenges:

• Entrepreneur testimonials: how to face financial and development challenges in an uncertain context?
• Asian opportunities for healthcare technology companies in Europe (China, Japan, South Korea),
• Macroeconomic environment and financial issues: implications for healthcare innovation and citizen access,
• Strengthening the diversity of healthcare technologies, from patients to investors,
• Processes and examples of mergers and acquisitions in the healthcare sector,
• Needs of European HealthTech companies and responses from industry and sector investors.

4. Placing the Patient at the Heart of Innovation:

This year, the 3rd edition of the HealthTech For Patients conference, organized by HealthTech For Care, brought together 15 international experts to discuss non-communicable diseases (NCDs), including cardiovascular diseases, to position the patient at the center of medical innovation.

About HealthTech For Care
The HealthTech For Care endowment fund is designed to support and promote access to healthcare for all, with a particular focus on new medical technologies and new medications. The fund's missions revolve around three main axes: supporting the development of the entire healthcare ecosystem, accelerating the development of innovative therapies and medications, and facilitating better patientaccess to the healthcare system in France and Europe.
The governance of HealthTech For Care brings together, under the leadership of its President Maryvonne Hiance, independent experts from the entire value chain of healthcare innovation for patients, including Elsy Boglioli, Pierre Courteille, Marc Dechamps, Christian Deleuze, Eric Falcand, Frédéric Girard, Marc Julien, Anaïs Le Corvec, Bernard Linsmeau, Cédric Moreau, Christian Pierret, and Christian Policard.

HealthTech For Care receives support from its founder France Biotech and the network of French healthcare competitiveness clusters, including Atlanpole biotherapies, BioValley France, EuroBioMed, LyonBioPole, Medicen, the clubster NHL and Technion France. The endowment fund is also backed by numerous European stakeholders, including Asebio, BIA Association, BioAlps, Biocentury, BIO Deutschland, BioRegio STERN, BioWin, CEBR, Danish LifeScience Cluster, Federchimica Assobiotec, flanders.bio, Medtech Europe, Medvia, Swiss Biotech.
https://htfc-eu.com

About HealthTech Innovation Days
HealthTech Innovation Days (HTID®), initiated by France Biotech and implemented by the HealthTech For Care endowment fund, provides a space for meeting between all stakeholders in the field of life sciences to bring innovation to patients. HTID brings together over 800 participants each year in Paris. The 5th edition will take place on October 24th and 25th, 2023, in Paris, and on October 27th, it will be virtual-only.
https://htfc-eu.com/htid/

About France Biotech
France Biotech was founded in 1997 as an independent association, uniting the country’s leading innovative health companies and their expert partners. As a leader in health innovation working in close cooperation with public authorities in France and across Europe, France Biotech is ideally positioned to address the challenges facing the HealthTech sector, notably corporate finance, taxation on innovation and regulatory and market access-related issues. Its committees and working groups strive to identify viable solutions to create the necessary conditions for a competitive and attractive industry. France Biotech’s mission is to support HealthTech startups and SMEs in their quest for international expansion and give them the capability to rapidly design and develop new innovations and get them to patients. France Biotech founded and developed the “HealthTech For Care” fund to bring together, structure and encourage cooperation between the various HealthTech stakeholders in France and Europe. Since September 2019, France Biotech is chaired by Franck Mouthon, CEO of Theranexus.